Evonile Pharma Limited (BOM:500672)
1,900.65
-36.65 (-1.89%)
At close: Oct 16, 2026
Evonile Pharma Market Cap
Evonile Pharma has a market cap or net worth of 46.93 billion as of October 16, 2026. It is the 14,595th most valuable company in the world and the 868th biggest in India. Its market cap has increased by 120.74% in one year.
Market Cap
46.93B
Enterprise Value
40.28B
Revenue
3.71B
Global Rank
Country Rank
#868 India
PE Ratio
48.00
ChartMarket Cap Chart
Since April 14, 1999, Evonile Pharma's market cap has increased from 12.59B to 46.93B, an increase of 272.88%. That is a compound annual growth rate of 4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 46.93B | 143.99% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 87.15B |
| Bliss GVS Pharma | 70.30B |
| Morepen Laboratories | 70.06B |
| Sanofi India | 68.71B |
| FDC Limited | 56.85B |
| Gufic Biosciences | 41.74B |
| Unichem Laboratories | 36.60B |
| Kwality Pharmaceuticals | 35.20B |